ror1 and its role in cll and other cancers
Published 6 years ago • 578 plays • Length 2:31Download video MP4
Download video MP3
Similar videos
-
1:37
the rationale behind targeting ror1 in cll and mcl
-
4:48
exciting insights into the role of ror1 in cll
-
2:40
ror1 signaling & its potential as a therapeutic target for leukemia
-
5:30
targeting ror1 and a two-drug approach to cure cll
-
1:04
new therapeutic targets in cll: ror1
-
4:17
how to approach r/r cll
-
9:25
mgus diagnosis: a step-by-step approach
-
9:41
subcutaneous epcoritamab in r/r b-cell non-hodgkin lymphoma
-
3:28
overview of 3 studies on cll therapy: data on ibrutinib and a ror1 inhibitor
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
3:33
a novel composite endpoint of toxicity and pfs in patients with r/r fl treated with axi-cel
-
1:29
nvg-111, a ror1 targeting bispecific tce, in r/r cll and mcl: a proof of concept phase i study
-
2:49
insights into the role of novel btkis in the treatment landscape of r/r cll
-
4:28
targeting the interaction between wnt5a and ror1 in cll
-
2:34
sequencing of therapies in patients with r/r cll
-
2:08
an insight into the current understanding of risk factors for cll
-
1:17
optimizing initial therapy in cll: time-limited, all-oral approaches
-
2:17
epcore cll-1: epcoritamab in patients with r/r cll & richter's transformation
-
2:17
updated analysis of bellwave-001: nemtabrutinib in r/r cll
-
3:17
transcend-cll-004 study update: safety and efficacy of liso-cel in r/r cll
-
2:08
the role of the foxo1-rictor-pakt axis in cll & how this impacts response to bcr inhibitors